Cargando…

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor

Detalles Bibliográficos
Autores principales:	Yoshimura, Yayoi, Shiino, Akihiko, Muraki, Kazue, Fukami, Tadateru, Yamada, Shigeki, Satow, Takeshi, Fukuda, Miyuki, Saiki, Masaaki, Hojo, Masato, Miyamoto, Susumu, Onishi, Nobuyuki, Saya, Hideyuki, Inubushi, Toshiro, Nozaki, Kazuhiko, Tanigaki, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755589/ https://www.ncbi.nlm.nih.gov/pubmed/26882340 http://dx.doi.org/10.1371/journal.pone.0149826

Ejemplares similares

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice
por: Sugita, Yoshito, et al.
Publicado: (2023)

CS-11 PITUITARY EPENDYMOMA: A CASE REPORT
por: Fukami, Tadateru, et al.
Publicado: (2019)

Neuronal migration abnormalities and its possible implications for schizophrenia
por: Muraki, Kazue, et al.
Publicado: (2015)

Diagnosis of demyelinating brain lesion simulating brain tumors on fast imaging employing steady-state acquisition magnetic resonance imaging
por: Onishi, Takeshi, et al.
Publicado: (2018)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

Germinoma in Two Brothers: Case Report
por: Nitta, Naoki, et al.
Publicado: (2013)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung.
por: Ishinishi, N, et al.
Publicado: (1977)

Mortality experience in relation to a measured arsenic trioxide exposure
por: Pinto, Sherman S., et al.
Publicado: (1977)

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
por: Sertel, Serkan, et al.
Publicado: (2012)

Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
por: Mathews, Vikram, et al.
Publicado: (2011)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011)

Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
por: Udensi, Udensi K, et al.
Publicado: (2011)

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats
por: Zhang, Weiqian, et al.
Publicado: (2014)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Arsenic trioxide rewires mantle cell lymphoma response to bortezomib
por: Zhao, Ling-Ling, et al.
Publicado: (2015)

Potassium Bromate Assay by Redox Titrimetry Using Arsenic Trioxide
por: Smeller, Johanna M., et al.
Publicado: (2003)

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
por: Zhang, Yun-Kai, et al.
Publicado: (2017)

PML-RARA mutations confer varying arsenic trioxide resistance
por: Bai, Dong-Mei, et al.
Publicado: (2016)

Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019)

Acute toxicity of intratracheal arsenic trioxide instillation in rat lungs
por: Mingxing, Su, et al.
Publicado: (2019)

Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
por: Kong, Degang, et al.
Publicado: (2020)

Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake
por: Han, Dingding, et al.
Publicado: (2021)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

ML-10 PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE CRANIAL VAULT: A CASE REPORT
por: Nitta, Naoki, et al.
Publicado: (2019)

Characteristics of cranial vault lymphoma from a systematic review of the literature
por: Nitta, Naoki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vh63bef9nuv1a8406jqkd01831